RE:USA exposureAurora IS IN THE USA.
In May 2020, Aurora acquired U.S. cannabidiol (CBD) producer, Reliva. This subsidiary holds the top-selling cannabinoid topical cream and the second most popular CBD brands overall (by some measures) in the nation. Before its acquisition, Reliva brought in about $10 million per year in sales.
Reliva's products are available online and in over 20,000 retail locations. Nearly half of America's biggest convenience stores sell the company's CBD. As more and more states join the legalization bandwagon, one should expect Reliva's sales (and, by proxy, Aurora's) to accelerate in the near future.